This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Pharmacyclics Inc
PCYC : NASDAQ : Health Care
$95.69 | %
Today's Range: 95.53 - 98.21
Avg. Daily Volume: 1,391,300
07/11/14 - 4:00 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
PCYC PHARMACYCLICS INC 97.16 7290.11 55.20 376.70 480.79
BMRN BIOMARIN PHARMACEUTICAL INC 59.06 8618.45 n/m 572.11 11.73
MDVN MEDIVATION INC 75.81 5801.28 n/m 313.98 64.36
CBST CUBIST PHARMACEUTICALS INC 67.92 5114.72 n/m 1085.75 14.94
ICPT INTERCEPT PHARMA INC 223.40 4724.02 n/m 1.62 21.68
SGEN SEATTLE GENETICS INC 36.33 4473.89 n/m 280.21 27.42
UTHR UNITED THERAPEUTICS CORP 92.95 4458.72 20.56 1161.25 21.34
ALXN ALEXION PHARMACEUTICALS INC 162.89 32218.99 99.32 1779.02 44.83
REGN REGENERON PHARMACEUTICALS 314.49 31096.77 90.37 2290.82 44.40
VRTX VERTEX PHARMACEUTICALS INC 97.82 23104.50 n/m 1002.06 -29.27
GRFS GRIFOLS SA 40.61 16427.69 26.72 4001.01 16.19
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

PCYC Ind Avg S&P 500
55.20 57.44 19.48

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs